Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001415889-24-009214

CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $66.93 ($1,003,978)

  • CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-03-25 Option exercise 10b5-1 +15,000 $1.79 $26,850 492,847 D
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-03-25 Sale 10b5-1 −13,450 $66.87 $899,361 479,397 D
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-03-25 Sale 10b5-1 −1,550 $67.50 $104,617 477,847 D
Derivatives
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-03-25 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,000 15,225 D
Open-market sales · 15,000 sh · avg $66.93 · $1,003,978
Loading xslF345X05/form4-03272024_080342.xml…